2.01CNY
226.57 MCNY
1.10 BCNY
36.22 M
About CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD.
Sector
CEO
Ming Xu Yuan
Headquarters
Chengdu
Website
Employees (FY)
1.4 K
Founded
2009
ISIN
CNE100004397
FIGI
BBG00NSMWTC8
Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and drug preparation. Its products include anti-tumor medicines such as Ubenimex capsules and ibandronate injections; cardiovascular medicines such as bisoprolol fumarate tablets; digestive medicines such as compound glycyrrhizin injections; anesthesia and analgesic products such as nalmefene hydrochloride injections and ibuprofen; and children’s medications. The company was founded by Ying Wang on June 1, 2009 and is headquartered in Chengdu, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688513 is 60.15 CNY — it has increased by 4.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. stocks are traded under the ticker 688513.
688513 stock is 4.94% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. there?
Yes, you can track CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. financials in yearly and quarterly reports right on TradingView.
688513 stock has risen by 5.60% compared to the previous week, the month change is a 3.78% rise, over the last year CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. has showed a 4.68% increase.
688513 net income for the last quarter is 75.01 M CNY, while the quarter before that showed 32.86 M CNY of net income which accounts for 128.28% change. Track more CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. financial stats to get the full picture.
Today CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. has the market capitalization of 6.92 B, it has increased by 3.15% over the last week.
Yes, 688513 dividends are paid annually. The last dividend per share was 0.56 CNY. As of today, Dividend Yield (TTM)% is 0.97%. Tracking CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. dividends might help you take more informed decisions.
CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. dividend yield was 0.91% in 2023, and payout ratio reached 30.73%. The year before the numbers were 0.92% and 27.28% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 688513 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 1.40 K employees. See our rating of the largest employees — is CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. stock shows the strong buy signal. See more of CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.